Add like
Add dislike
Add to saved papers

Factors impacting asthma control in children in a low-to-middle income country setting: a retrospective study.

OBJECTIVES: 1) To assess asthma control and its evolution over time among children in a low-to-middle-income country, and 2) to explore whether demographics, type of asthma medication, comorbidities or exacerbations impact asthma control.

METHODS: In a retrospective study in children with asthma aged 6-18 years conducted between 2005 and 2010, we collected clinical and demographic data and used Global Initiative for Asthma (GINA) criteria to assess asthma control. Proportions of children with well-controlled, partially controlled and uncontrolled asthma were calculated. Associations between different time points for lung function were investigated using Pearson correlation coefficients. Mixed effect regression analysis was used to investigate the effect of demographics, medication, comorbidity and exacerbations on lung function.

RESULTS: According to GINA criteria, asthma was well controlled in 44.9% of 189 enrolled children. Choice of add-on treatment and doubling the dose of inhaled corticosteroids, long-acting β-agonist or leukotriene receptor antagonists did not affect lung function tests (all P > 0.05). On mixed-model analysis, there was a correlation between duration of asthma treatment and forced expiratory volume in 1 s (FEV1) % predicted (P < 0.05). Exacerbations and uncontrolled asthma had a negative impact on FEV1 % predicted (P < 0.05). Therapeutic decisions were guided by spirometry results in only 21% of cases.

CONCLUSION: Asthma control was not achieved in the majority of the children. Choice of step-up therapy did not impact asthma control or lung function.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app